Friday, July 27, 2012

NVS - Adjustment

The following adjustment was made today on Novartis (NVS). All prices include IB commissions.

CriteriaValue
Dividend Champions StatusContender
Years of Consecutive Dividend Increases10
Fair Value Estimate$69.00*
Target Buy Price$55.20
Target Margin of Safety20.00%
Actual Buy Price$55.00
Actual Margin of Safety20.29%

*Fair Value was lowered from $71 to $69 since inception with no impact on my original Margin of Safety.

DateStockDescriptionTransactionStatusStock InvestmentIncome Generated
7/27/2012NVSContinued TradeSTO 1 Sep12 60.00 Call @ 0.54  $54.25

Current Position Summary

Cost Basis($5,250.00)
Income Generated$222.94
Percent Income Generated4.25%
Annualized Income Generated6.46%
Net Profit If Assigned$972.94
Percent Return If Assigned18.53%
Annualized Return If Assigned28.18%
Days Held to Expiration240 days

Trade History

DateStockDescriptionTransactionStatusStock InvestmentIncome Generated
1/25/2012NVSCSP Margin UsedCSP 100 NVS @ 52.50 ($5,250.00) 
1/25/2012NVSInitial Put OptionSTO 1 Mar12 52.50 Put @ 1.18Expired $117.97
3/22/2012NVSContinued TradeSTO 1 May12 52.50 Put @ 0.51Exercised $50.72
5/18/2012NVSCSP Margin ReturnedCSP 100 NVS @ -52.50 $5,250.00 
5/18/2012NVSStock AssignedEX 1 May12 52.50 Put @ -52.50 ($5,250.00) 
7/27/2012NVSContinued TradeSTO 1 Sep12 60.00 Call @ 0.54  $54.25
9/21/2012NVS Totals ($5,250.00)$222.94
DTE240 Percent Income/Annualized 4.25%6.46%